Amrize Ltd (AMRZ)vsCemex SAB de CV ADR (CX)
AMRZ
Amrize Ltd
$37.90
-2.82%
BASIC MATERIALS · Cap: $20.89B
CX
Cemex SAB de CV ADR
$9.76
-2.66%
BASIC MATERIALS · Cap: $14.52B
Smart Verdict
WallStSmart Research — data-driven comparison
Cemex SAB de CV ADR generates 40% more annual revenue ($17.04B vs $12.18B). AMRZ leads profitability with a 10.1% profit margin vs 2.8%. CX appears more attractively valued with a PEG of 0.11. AMRZ earns a higher WallStSmart Score of 68/100 (B-).
AMRZ
Strong Buy68
out of 100
Grade: B-
CX
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AMRZ.
Margin of Safety
+25.2%
Fair Value
$13.40
Current Price
$9.76
$3.64 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 20.5%
Growing faster than its price suggests
Reasonable price relative to book value
Areas to Watch
Distress zone — elevated risk
Weak financial health signals
Moderate valuation
0.0% earnings growth
ROE of 3.9% — below average capital efficiency
2.8% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : AMRZ
The strongest argument for AMRZ centers on PEG Ratio, P/E Ratio, Price/Book. PEG of 1.00 suggests the stock is reasonably priced for its growth.
Bull Case : CX
The strongest argument for CX centers on PEG Ratio, Price/Book. Revenue growth of 12.2% demonstrates continued momentum. PEG of 0.11 suggests the stock is reasonably priced for its growth.
Bear Case : AMRZ
The primary concerns for AMRZ are Altman Z-Score, Piotroski F-Score.
Bear Case : CX
The primary concerns for CX are P/E Ratio, EPS Growth, Return on Equity. Thin 2.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
CX is growing revenue faster at 12.2% — sustainability is the question.
CX generates stronger free cash flow (582M), providing more financial flexibility.
Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
AMRZ scores higher overall (68/100 vs 59/100). CX offers better value entry with a 25.2% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Amrize Ltd
BASIC MATERIALS · BUILDING MATERIALS · USA
Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.
Visit Website →Cemex SAB de CV ADR
BASIC MATERIALS · BUILDING MATERIALS · USA
CEMEX, SAB de CV, produces, markets, distributes and sells cement, ready-mix concrete, aggregates, clinker and other construction materials worldwide. The company is headquartered in San Pedro Garza Garca, Mexico.
Compare with Other BUILDING MATERIALS Stocks
Want to dig deeper into these stocks?